Insider trades
Daniel Karlin, Chief Officer of Definium Therapeutics DFTX, has filed 0 purchases and 17 sales on the open market. Over the past 12 months that comes to a net sale of $1.1M. The latest trade was on 09/25.
Daniel Karlin
Chief Medical Officer
- Company
- Definium Therapeutics DFTX
- First filing
- 23/03/02
- Trades
- 22 trades
- Buys / sales
- 0 / 17
- 12-month net buying
- −$1.1M
- Last trade
- 09/25
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 09/25 | 09/29 | 10,853 sh | $36.57 | $396,894.21 | −1.4% | |
| Open-market sale10b5-1 plan | 06/25 | 06/26 | 10,035 sh | $45.03 | $451,876.05 | −2.0% | |
| Open-market sale10b5-1 plan | 03/25 | 03/26 | 8,018 sh | $18.47 | $148,092.46 | −1.9% | |
| Open-market sale10b5-1 plan | 25/12/26 | 25/12/29 | 5,600 sh | $13.15 | $73,640 | −1.3% | |
| Open-market sale10b5-1 plan | 25/09/25 | 25/09/26 | 7,704 sh | $9.77 | $75,268.08 | −1.8% | |
| Open-market sale10b5-1 plan | 25/06/25 | 25/06/26 | 7,848 sh | $6.80 | $53,366.4 | −1.8% | |
| Open-market sale10b5-1 plan | 25/03/25 | 25/03/26 | 6,836 sh | $6.74 | $46,074.64 | −1.5% | |
| Open-market sale10b5-1 plan | 24/12/26 | 24/12/27 | 6,643 sh | $7.43 | $49,357.49 | −1.9% | |
| Open-market sale10b5-1 plan | 24/09/25 | 24/09/25 | 6,871 sh | $5.98 | $41,088.58 | −2.0% | |
| Open-market sale10b5-1 plan | 24/06/25 | 24/06/25 | 6,925 sh | $7.22 | $49,998.5 | −1.9% | |
| Open-market sale10b5-1 plan | 24/03/25 | 24/03/26 | 6,578 sh | $9.50 | $62,491 | −1.8% | |
| Open-market sale | 23/12/26 | 23/12/26 | 6,774 sh | $3.63 | $24,589.62 | −1.8% | |
DFTX | Open-market sale | 23/09/25 | 23/09/25 | 6,918 sh2 trades | $3.57avg. | $24,729.66 | −1.8% |
DFTX | Open-market sale | 23/06/27 | 23/06/27 | 6,783 sh2 trades | $3.20avg. | $21,697.03 | −1.8% |
| Open-market sale | 23/03/01 | 23/03/02 | 3,577 sh | $3.51 | $12,555.27 | −1.4% |